Gilead (GILD) Receives $31M from NHS England for Hep C Treatment, Sovaldi
Tweet Send to a Friend
Gilead Sciences (Nasdaq: GILD) is said to be in an investment pact with NHS England over Sovaldi.According to Reuters, National ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE